Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Iovance granted inducement stock options covering 111,615 shares to 21 new non-executive employees under its 2021 Inducement Plan. The options carry a $14.72 exercise price, matching the October 15 closing price, and vest over three years.
Key figures
- New employees
- 21
- Exercise price
- 14.72
- Inducement option shares
- 111615
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.